Cidara Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS

Abstract:

The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.